You are here

  • Home
  • Archive
  • Volume 94, Issue 2
  • Population-based Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis prevalence using discarded, deidentified urine specimens previously collected for drug testing

Article Text

Article menu

Download PDFPDF

Epidemiology
Population-based Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis prevalence using discarded, deidentified urine specimens previously collected for drug testing
  1. Judith Harbertson1,2,3,
  2. Matthew Jamerson4,
  3. Paul C F Graf5,6,
  4. Lisa Kennemur4,
  5. Brent House5,
  6. Nelson L Michael1,
  7. Paul Scott1,
  8. Brad Hale3,7
  1. 1 US Military HIV Research Program, Walter Reed Army Institute of Research, San Diego, California, USA
  2. 2 Health Sciences Business Unit, Leidos, Inc, San Diego, California, USA
  3. 3 Department of Defense HIV/AIDS Prevention Program (DHAPP), Naval Health Research Center, San Diego, California, USA
  4. 4 Navy Drug Screening Laboratory, US Navy, San Diego, California, USA
  5. 5 Naval Medical Center, San Diego, California, USA
  6. 6 Operational Infectious Diseases Department, Naval Health Research Center, San Diego, California, USA
  7. 7 University of California, San Diego, California, USA
  1. Correspondence to Dr Judith Harbertson, US Military HIV Research Program, Naval Health Research Center, San Diego 92152, California, USA; judith.harbertson.ctr{at}mail.mil

https://doi.org/10.1136/sextrans-2017-053355

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We used a novel method to test for STIs among a non–healthcare-seeking military population in the San Diego region of California. Active-duty US Navy and Marine Corps personnel were randomly selected to provide urine specimens to Navy Drug Screening Laboratory, San Diego in October and November 2013 for the Department of Defense drug testing programme. If specimens screened negative for drugs (>99% of samples), urine specimens were discarded, deidentified and subsequently tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC) and Trichomonas vaginalis (TV) using the Aptima Combo 2 and TV assay as specified by the manufacturer (Hologic, San Diego, CA, USA). The Tigris direct tube sampling system was used for high-throughput nucleic acid amplification testing (NAAT). Urine specimens older than 6 days were not tested due to sample degradation concerns.

    The overall prevalence of CT was 2.1% (95% CI 1.79 …

    View Full Text